2023-05-10 11:18:45
New research shows that a popular drug, often prescribed by doctors to treat obesity and type 2 diabetes, may have benefits in fighting cancer.
According to Study Finds, one out of every 3 adults in the United States is obese, and 13 percent of the world’s adult population is significantly overweight.
Obesity-related cancers account for 40 percent of all cancers diagnosed by doctors in the United States each year, and this is because anti-cancer immune cells are rendered “useless or neutralized” by obesity.
A team from the University of Maynooth in Ireland found that the glucagon-like peptide “GLP-1” is a “golden” pharmacological approach to fighting obesity, highlighting that the treatment has also shown its ability to activate the human body’s natural mechanisms to destroy cancer cells.
According to “Study Finds”, the authors of the study said that “GLP-1” can restore the functions of anti-cancer immune cells, noting that this matter occurs independently of the main weight loss function of this drug.
“My team and I are very excited regarding these new findings regarding the effects of GLP-1 therapy in people with obesity, and its benefits extend to reducing cancer risk,” said Andrew E. Hogan, the study’s principal investigator.
1683734410
#popular #obesity #treatment #fight #cancer
